Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Cardiovascular Market Research

NA Stroke Market - Industry Trends and Forecast to 2034

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 230 Pages Data Bridge Market Research October, 2023 DAABD18360532
Best Price Guarantee
Price from $3,500
Length 230 Pages
Publisher Data Bridge Market Research
Published Date October, 2023
SKU DAABD18360532

NA Stroke Market - Industry Trends and Forecast to 2034


North America Stroke market is projected to register a CAGR of 7.3% in the forecast period of 2023 to 2030. The new market report contains data for historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
North America Stroke Market, By Type (Ischemic Stroke, Transient Ischemic Attack (TIA) and Hemorrhage Stroke), Diagnosis (Imaging Test, Blood Test, Echocardiogram, Lumbar Puncture, and Other), Treatment (Medication, Other Therapy, and Surgery), Gender (Female and Male), End-User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories and Others), Distribution Channel (Direct Tender, Retail Sales And Online Sales) Country (U.S., Canada and Mexico) – Industry trends and forecast to 2030
Overview of North America Stroke Market Dynamics

Drivers
• Rising incidences of stroke
• Increasing number of patients with hypertension and coronary heart diseases

Restraints

• High cost associated with treatment of stroke
• Side-effects associated with medication

Opportunities

• Expansion of telemedicine and remote monitoring
• Innovative therapies in pipeline for stroke treatment

Market Players
Some of the major market players operating in the North America stroke market are:
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH.
• F. Hoffmann-La Roche Ltd
• DAIICHI SANKYO COMPANY, LIMITED.
• Sanofi
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sandoz AG
• Pfizer Inc.
• Medtronic
• Abbott
• Viatris Inc.
• AstraZeneca
• Penumbra, Inc.
• GLENMARK PHARMACEUTICALS LTD
• Fresenius Kabi USA
• Teva Pharmaceuticals USA, Inc.
• Lupin
• Amneal Pharmaceuticals LLC.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Stroke Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Application Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's 5 Forces
5 Epidemiology
6 North America Stroke Market, Regulatory Framework
6.1 Regulation In U.S
6.2 Regulation In Europe
6.3 Regulation In China
6.4 Regulation In Japan
6.5 Regulation In South Africa
7 Market Overview
7.1 Drivers
7.1.1 Rising Incidences Of Stroke
7.1.2 Increasing Number Of Patients With Hypertension And Coronary Heart Diseases
7.1.3 Increasing Diabetic And Obese Population
7.1.4 Advancements In Medical Technology For Stroke Treatment
7.2 Restraints
7.2.1 High Cost Associated With Treatment Of Stroke
7.2.2 Side-effects Associated With Medication
7.3 Opportunities
7.3.1 Expansion Of Telemedicine And Remote Monitoring
7.3.2 Innovative Therapies In Pipeline For Stroke Treatment
7.4 Challenges
7.4.1 Inaccurate Diagnosis Of Strokes S
7.4.2 Complications In Managing Stroke In Patients With Multiple Chronic Conditions
8 North America Stroke Market, By Type
8.1 Overview
8.2 Ischemic Stroke
8.2.1 Thrombotic (Cerebral Thrombosis)
8.2.2 Embolic (Cerebral Embolism)
8.3 Hemorrhagic Stroke
8.3.1 Subarachnoid Hemorrhage
8.3.2 Intracerebral Hemorrhage
8.4 Transient Ischemic Attack (Tia)
9 North America Stroke Market, By Treatment
9.1 Overview
9.2 Medication
9.2.1 By Class
9.2.1.1 Blood Pressure Medicines
9.2.1.1.1 Angiotensin-converting Enzyme (Ace) Inhibitors
9.2.1.1.1.1 Ramipril
9.2.1.1.1.2 Lisinopril
9.2.1.1.1.3 Enalapril
9.2.1.1.1.4 Perindopril
9.2.1.1.1.5 Other 80 
9.2.1.1.2 Diuretics
9.2.1.1.2.1 Indapamide
9.2.1.1.2.2 Bendroflumethiazide
9.2.1.1.2.3 Spironolactone
9.2.1.1.2.4 Amiloride
9.2.1.1.2.5 Other
9.2.1.1.3 Calcium Channel Blockers
9.2.1.1.3.1 Amlodipine
9.2.1.1.3.2 Nifedipine
9.2.1.1.3.3 Verapamil
9.2.1.1.3.4 Nicardipine
9.2.1.1.3.5 Felodipine
9.2.1.1.3.6 Nimodipine
9.2.1.1.3.7 Other
9.2.1.1.4 Beta Blockers
9.2.1.1.4.1 Atenolol
9.2.1.1.4.2 Bisoprolol
9.2.1.1.4.3 Labetolol
9.2.1.1.4.4 Other
9.2.1.1.5 Alpha Blockers
9.2.1.1.5.1 Doxazosin
9.2.1.1.5.2 Other
9.2.1.1.6 Others
9.2.1.1 Antiplatelet Drugs
9.2.1.1.1 Aspirin
9.2.1.1.2 Clopidogrel
9.2.1.1.3 Dipyridamole
9.2.1.1.4 Ticlopidine
9.2.1.1.5 Others
9.2.1.2 Anticoagulants
9.2.1.2.1 Warfarin
9.2.1.2.2 Apixaban
9.2.1.2.3 Dabigatran
9.2.1.2.4 Heparin
9.2.1.2.5 Rivaroxaban
9.2.1.2.6 Others
9.2.1.3 Tissue Plasminogen Activator (Tpa)
9.2.1.3.1 Alteplase
9.2.1.3.2 Tenecteplase
9.2.1.3.3 Reteplase
9.2.1.3.4 Anistreplase
9.2.1.3.5 Others
9.2.1.4 Statins
9.2.1.4.1 Atorvastatin
9.2.1.4.2 Simvastatin
9.2.1.4.3 Lovastatin
9.2.1.4.4 Rosuvastatin
9.2.1.4.5 Fluvastatin
9.2.1.4.6 Pravastatin
9.2.1.4.7 Pitavastatin
9.2.1.4.8 Others
9.2.1.5 Vitamin K
9.2.1.6 Supportive Medication
9.2.1.6.1 Nutritional Supplements
9.2.1.6.2 Antipyretics
9.2.1.6.3 Others
9.2.2 By Drug Type
9.2.2.1 Generics
9.2.2.2 Branded
9.2.2.2.1 Eliquis
9.2.2.2.2 Pradaxa
9.2.2.2.3 Activase
9.2.2.2.4 Aspirin
9.2.2.2.5 Plavix
9.2.2.2.6 Aggrenox
9.2.2.2.7 Others
9.2.3 By Route Of Administration
9.2.3.1 Oral
9.2.3.1.1 Tablet
9.2.3.1.2 Capsules
9.2.3.1.3 Others
9.2.3.2 Parenteral
9.2.3.2.1 Intravenous
9.2.3.2.2 Subcutaneous
9.2.3.3 Others
9.2.4 By Mode Of Purchase
9.2.4.1 Prescription
9.2.4.2 Over The Counter (Otc)
9.2.5 By Therpay Type
9.2.5.1 Combination Therapy
9.2.5.2 Monotherapy
9.3 Surgery
9.3.1 Embolic Coils
9.3.2 Aspiration Catheters
9.3.3 Stent Retriever
9.3.4 Surgical Clipping
9.3.5 Others
9.4 Other Therapy
9.4.1 Physical Therapy
9.4.2 Occupational Therapy
9.4.3 Speech Therapy
9.4.4 Others
10 North America Stroke Market, By Diagnosis
10.1 Overview
10.2 Imaging Test
10.2.1 Computerized Tomography (Ct) Scan
10.2.2 Magnetic Resonance Imaging (Mri)
10.2.3 Carotid Ultrasound
10.2.4 Cerebral Angiogram
10.3 Blood Test
10.4 Echocardiogram
10.5 Lumbar Puncture
10.6 Others
11 North America Stroke Market, By Gender
11.1 Overview
11.2 Female
11.3 Male
12 North America Stroke Market, By End User
12.1 Overview
12.2 Hospitals & Clinics
12.3 Specialty Clinics
12.4 Ambulatory Surgical Center
12.5 Homecare
12.6 Laboratories
12.7 Others
13 North America Stroke Market, By Distribution Channel
13.1 Overview
13.2 Direct
13.3 Retail
13.4 Online
14 North America Stroke Market, By Region
14.1 North America
14.1.1 U.S.
14.1.2 Canada
14.1.3 Mexico
15 North America Stroke Market, Company Landscape
15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profiles
17.1 Bristol-myers Squibb Company
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Boehringer Ingelheim International Gmbh
17.2.1 Company Snapshot
17.2.2 Product Portfolio
17.2.3 Company Share Analysis
17.2.4 Recent Development
17.3 F. Hoffmann-la Roche Ltd
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Daiichi Sankyo Company, Limited
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Sanofi
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Abbott
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Amneal Pharmaceuticals Llc
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Astrazeneca
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Bayer Ag
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Development
17.10 Fresenius Se & Co. Kgaa
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Glenmark Pharmaceuticals Ltd.
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Johnson & Johnson Services, Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Development
17.13 Lupin
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Product Portfolio
17.13.4 Recent Development
17.14 Medtronic
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Oxford Laboratories Pvt. Ltd.
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Penumbra, Inc.
17.16.1 Company Snapshot
17.16.2 Revenue Analysis
17.16.3 Product Portfolio
17.16.4 Recent Development
17.17 Pfizer Inc.
17.17.1 Company Snapshot
17.17.2 Revenue Analysis
17.17.3 Product Portfolio
17.17.4 Recent Development
17.18 Sandoz Group Ag (Subsidiary Of Novartis Ag)
17.18.1 Company Snapshot
17.18.2 Revenue Analysis
17.18.3 Product Portfolio
17.18.4 Recent Development
17.19 Teva Pharmaceuticals Usa, Inc.
17.19.1 Company Snapshot
17.19.2 Revenue Analysis
17.19.3 Product Portfolio
17.19.4 Recent Development
17.20 Viatris Inc.
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 North America Stroke Market, By Type, 2022-2030 (Usd Thousand)
Table 2 North America Ischemic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 3 North America Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 4 North America Hemorrhagic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 5 North America Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 6 North America Transient Ischemic Attack (Tia) In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 7 North America Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 8 North America Medication In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 9 North America Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 10 North America Blood Pressure Medicines In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 11 North America Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 12 North America Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 13 North America Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 14 North America Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 15 North America Alpha Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 16 North America Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 17 North America Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 18 North America Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 19 North America Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 20 North America Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 21 North America Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 22 North America Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 23 North America Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 24 North America Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 25 North America Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 26 North America Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 27 North America Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 28 North America Surgery In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 29 North America Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 30 North America Other Therapy In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 31 North America Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 32 North America Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 33 North America Imaging Test In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 34 North America Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 35 North America Blood Test In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 36 North America Echocardiogram In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 37 North America Lumbar Puncture In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 38 North America Others In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 39 North America Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 40 North America Female In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 41 North America Male In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 42 North America Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 43 North America Hospitals & Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 44 North America Specialty Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 45 North America Ambulatory Surgical Center In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 46 North America Homecare In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 47 North America Laboratories In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 48 North America Others In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 49 North America Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 50 North America Direct In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 51 North America Retail In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 52 North America Online In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 53 North America Stroke Market, By Country, 2021-2030 (Usd Thousand)
Table 54 North America Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 55 North America Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 56 North America Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 57 North America Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 58 North America Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 59 North America Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 60 North America Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 61 North America Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 62 North America Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 63 North America Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 64 North America Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 65 North America Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 66 North America Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 67 North America Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 68 North America Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 69 North America Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 70 North America Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 71 North America Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 72 North America Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 73 North America Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 74 North America Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 75 North America Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 76 North America Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 77 North America Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 78 North America Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 79 North America Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 80 North America Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 81 North America Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 82 North America Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 83 North America Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 84 North America Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 85 U.S. Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 86 U.S. Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 87 U.S. Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 88 U.S. Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 89 U.S. Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 90 U.S. Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 91 U.S. Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 92 U.S. Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 93 U.S. Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 94 U.S. Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 95 U.S. Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 96 U.S. Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 97 U.S. Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 98 U.S. Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 99 U.S. Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 100 U.S. Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 101 U.S. Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 102 U.S. Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 103 U.S. Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 104 U.S. Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 105 U.S. Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 106 U.S. Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 107 U.S. Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 108 U.S. Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 109 U.S. Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 110 U.S. Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 111 U.S. Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 112 U.S. Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 113 U.S. Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 114 U.S. Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 115 U.S. Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 116 Canada Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 117 Canada Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 118 Canada Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 119 Canada Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 120 Canada Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 121 Canada Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 122 Canada Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 123 Canada Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 124 Canada Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 125 Canada Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 126 Canada Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 127 Canada Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 128 Canada Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 129 Canada Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 130 Canada Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 131 Canada Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 132 Canada Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 133 Canada Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 134 Canada Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 135 Canada Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 136 Canada Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 137 Canada Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 138 Canada Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 139 Canada Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 140 Canada Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 141 Canada Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 142 Canada Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 143 Canada Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 144 Canada Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 145 Canada Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 146 Canada Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 147 Mexico Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 148 Mexico Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 149 Mexico Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Stroke Market: Segmentation
Figure 2 North America Stroke Market: Data Triangulation
Figure 3 North America Stroke Market: Droc Analysis
Figure 4 North America Stroke Market : North America Vs Regional Market Analysis
Figure 5 North America Stroke Market: Company Research Analysis
Figure 6 North America Stroke Market: Interview Demographics
Figure 7 North America Stroke Market: Dbmr Market Position Grid
Figure 8 North America Stroke Market: Market Application Coverage Grid
Figure 9 North America Stroke Market: Vendor Share Analysis
Figure 10 North America Stroke Market: Segmentation
Figure 11 Increasing Number Of Patients With Hypertension And Coronary Heart Disease Is Expected To Drive The North America Stroke Market Growth In The Forecast Period Of 2023 To 2030
Figure 12 Ischemic Stroke Segment Is Expected To Account For The Largest Share Of The North America Stroke Market In The Forecast Period Of 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Stroke Market
Figure 14 North America Stroke Market: By Type, 2022
Figure 15 North America Stroke Market: By Type, 2023-2030 (Usd Thousand)
Figure 16 North America Stroke Market: By Type, Cagr (2023-2030)
Figure 17 North America Stroke Market: By Type, Lifeline Curve
Figure 18 North America Stroke Market: By Treatment, 2022
Figure 19 North America Stroke Market: By Treatment, 2023-2030 (Usd Million)
Figure 20 North America Stroke Market: By Treatment, Cagr (2023-2030)
Figure 21 North America Stroke Market: By Treatment, Lifeline Curve
Figure 22 North America Stroke Market: By Diagnosis, 2022
Figure 23 North America Stroke Market: By Diagnosis, 2023-2030 (Usd Thousand)
Figure 24 North America Stroke Market: By Diagnosis, Cagr (2023-2030)
Figure 25 North America Stroke Market: By Diagnosis, Lifeline Curve
Figure 26 North America Stroke Market: By Gender, 2022
Figure 27 North America Stroke Market: By Gender, 2023-2030 (Usd Thousand)
Figure 28 North America Stroke Market: By Gender, Cagr (2023-2030)
Figure 29 North America Stroke Market: By Gender, Lifeline Curve
Figure 30 North America Stroke Market: By End User, 2022
Figure 31 North America Stroke Market: By End User, 2023-2030 (Usd Thousand)
Figure 32 North America Stroke Market: By End User, Cagr (2023-2030)
Figure 33 North America Stroke Market: By End User, Lifeline Curve
Figure 34 North America Stroke Market: By Distribution Channel, 2022
Figure 35 North America Stroke Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 36 North America Stroke Market: By Distribution Channel, Cagr (2023-2030)
Figure 37 North America Stroke Market: By Distribution Channel, Lifeline Curve
Figure 38 North America Stroke Market: Snapshot (2022)
Figure 39 North America Stroke Market: Company Share 2022 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings